#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Peritoneal neoplasm Oesophageal carcinoma Chronic cutaneous lupus erythematosus Acute graft versus host disease in intestine Glioblastoma Ventricular fibrillation Congenital growth hormone deficiency Red blood cell abnormality Neurodegenerative disorder Propionic acidaemia Acquired haemophilia Diabetes insipidus Hepatitis D Ocular lymphoma Autoimmune myositis More trials…

Learn about Rare Diseases

Indolent systemic mastocytosis – Basic Information Gastrointestinal stromal tumour – Trials in Disease Urea cycle disorder – Diagnostics Cerebral arteriovenous malformation haemorrhagic Gastrointestinal stromal tumour – Life with Disease Metachromatic leukodystrophy – Trials in Disease Waldenstrom’s macroglobulinaemia – Trials in Disease Lymphangiosarcoma – Life with Disease Aicardi-Goutieres syndrome – Diagnostics Chondrosarcoma – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Retifanlimab Lorlatinib Sodium Phenylbutyrate Syn2 AB521 AVTX-009 Bicalutamide Rupatadine Ambroxol Hydrochloride Arachis Hypogaea Extract Cetirizine Burfiralimab Tipiracil Hydrochloride Erdafitinib Tipapkinogene Sovacivec Lumateperone Quizartinib Dihydrochloride Dexibuprofen Rmc-035 Cinchocaine Hydrochloride More therapies…

Learn about Your Condition

Malformation venous Neurodevelopmental disorder CDKL5 deficiency disorder Hypersensitivity Erosive oesophagitis Asymptomatic HIV infection Neurofibrosarcoma Renal impairment Cholangiocarcinoma Rheumatic disorder Ischaemic skin ulcer Intracranial calcification Eructation Myocardial infarction Lung adenocarcinoma stage IV More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Triple negative breast cancer

Study of Atezolizumab and RP1 for Patients with Early-Stage Triple-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
- Rp1
- Atezolizumab
Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
+2
Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- ZELENECTIDE PEVEDOTIN

1 … 10 11 12

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Triple negative breast cancer

Study of Atezolizumab and RP1 for Patients with Early-Stage Triple-Negative Breast Cancer

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies